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Death to Carbohydrate Counting?
I
nsulin therapy is an effective strategy
for achieving glycemic control in pa-
tients with type 2 diabetes. Although
often neglected, it is important to use an
appropriate diet strategy to complement
the insulin. Furthermore, a basic tenet of
such therapy is that insulin dosage and
administration should be appropriate to
balance diet and physical activity in order
to maintain normoglycemia.
In this issue of Diabetes Care, Bergen-
stal et al. (1) evaluated two strategies for
determining the appropriate dosage of
mealtime bolus insulin. A simple algo-
rithm that adjusted bolus insulin dose
based on weekly average of premeal glu-
cose was compared with an algorithm
based on mealtime carbohydrate count-
ing. The authors demonstrated the equiv-
alence of both the simple strategy and the
more elaborate carbohydrate-counting
strategy in achieving glycemic control; al-
most one-half the participants in both
groups achieved an A1C 6.5%. Can pa-
tients with type 2 diabetes treated with
basal:bolus insulin succeed without add-
ing the complexity of carbohydrate
counting?
Carbohydrate counting has been
around since the 1920s and became inte-
gral in managing patients with type 1 di-
abetes after the landmark ﬁndings of the
DiabetesControlandComplicationsTrial
(2).However,theefﬁcacyofcarbohydrate
counting in type 2 diabetes is largely un-
known.Potentialbarrierstocarbohydrate
counting include the time and effort re-
quired for patients to count the carbohy-
drate content at each meal, patient
difﬁculties in understanding the strategy,
and the availability of dietitians or appro-
priately trained health care providers to
teach patients. The authors did not eval-
uate quality-of-life outcomes, and little is
knownabouthowcarbohydratecounting
affects quality of life. Prior studies have
demonstrated that, when given a choice,
patients opt to discontinue carbohydrate
countingoverotherstrategies(3).Further
research is clearly needed on the optimi-
zation of carbohydrate counting in type 2
diabetes and also in assessment of the ac-
curacy of patients’ counting in the real
world setting.
Itwouldappearthatifsimilarlevelsof
glycemiccontrolcanbeachievedwithfew
adverse events by using a simple algo-
rithm,thenthesimplealgorithmmaybea
better strategy for adjusting insulin. Ad-
ditionally, the simple algorithm may be
more feasible to teach patients within un-
derserved settings where a dietitian may
not be available. However, are there ben-
eﬁts to counting carbohydrates beyond
glycemic control?
In examining the study’s secondary
outcomes, there is an apparent trend for
the carbohydrate-counting group to have
less weight gain at the end of the 24-week
period. The carbohydrate group had a
weight gain of 2.3% compared with a
3.4% increase in the simple algorithm
group. The 1% difference in weight gain
over6monthsdidnotreachstatisticalsig-
niﬁcance, but the study was not ade-
quatelypoweredtotestthesigniﬁcanceof
such a difference. What would be the
weight effects over a longer time period?
Could the higher insulin dosage used in
the simple algorithm group cause greater
weight gain? Weight gain is a well-known
side effect of insulin therapy, and previ-
ous studies demonstrate weight increases
of 21% in one year with some insulin
regimens (4). Weight management is a
critical aspect of type 2 diabetes, and it
will be important to evaluate strategies to
minimize weight gain while using insulin
therapy. Reducing carbohydrates can be
an important strategy for improving gly-
cemic control and weight loss. Did the
carbohydrate-counting group have a
lower carbohydrate or caloric intake than
the simple algorithm group? The Look
AHEAD (Action for Health in Diabetes)
Trial, which is evaluating the potential
beneﬁts of weight control in type 2 diabe-
tes, found that the three most common
weight control strategies used by partici-
pants were increasing fruits and vegeta-
bles, cutting out sweets, and eating fewer
high-carbohydrate foods (5). Counting
carbohydrates may increase dietary
awareness of the carbohydrates being
consumed and subsequently reduce car-
bohydrate consumption.
A greater number of patients in the
simple algorithm group completed the
study in comparison with the carbohy-
drate-counting groups (91.2 vs. 79.6%),
whichmaysuggestgreatereaseofcompli-
ancewiththesimplealgorithm.Theover-
all adverse event rate was similar between
the treatment groups, but reported self-
blood glucose monitoring 50 mg/dl
with symptoms was slightly more com-
mon in the carbohydrate-counting than
in the simple algorithm group. Although
therewasnostatisticallysigniﬁcantdiffer-
ence in the rates of hypoglycemia with
using either dosing algorithm, the simple
algorithm had 53 episodes of hypoglyce-
mia in 19 patients, whereas the carbohy-
drate counting group had 37 episodes in
19 patients. Although the reasons for this
are unclear, we question whether this re-
ﬂects more real-time adjustment in bolus
insulin dose in the carbohydrate group
ratherthantheweeklyadjustmentindose
in the simple algorithm.
Insulin management continues to be
complex and requires close monitoring
both by patients and their physicians.
Bergenstal et al. (1) have developed an
algorithm to simplify the management of
insulin regimens containing basal and
mealtime insulin. Patients with type 2 di-
abetes may achieve glycemic targets with
a simple basal:bolus insulin algorithm
withouttheaddedburdenofcountingthe
carbohydrate content of each meal. Gly-
cemic control, however, is one of many
aspects of diabetes management, and we
need to be mindful of other important as-
pects including weight control and risks
of hypoglycemia. Bergenstal et al. have
certainly initiated the impetus for us to
examine the relevance of carbohydrate
counting for insulin dosing in type 2 dia-
betes, but carbohydrate counting may
have a life for more than just medication
adjustment.
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